The Cannabis Sector Is Ready for an Implosion: 1,500% Acquisition Premiums Make No Sense

Why Aphria Inc. (TSX:APH) agreeing to buy Broken Coast Cannabis Inc. for $230 million is a valuation exercise which needs to be completed in some alternative dimension where fundamentals do not matter.

With most Canadian cannabis producers now swimming in a sea of “funny money,” some funny math has taken over in the acquisition metrics used by firms such as Aphria Inc. (TSX:APH) in agreeing to buy Broken Coast Cannabis Inc. for $230 million on earlier this week, as covered by fellow Fool contributor Joseph Solitro.

While Mr. Solitro appears to be very bullish on the long-term prospects of Aphria following the announcement of this acquisition as well as a couple of other recent strategic moves made by Aphria, looking at the multiple paid for Broken Coast, I’m surprised the stock didn’t tank the minute the acquisition was announced.

According to Chris Damas of BCMI Research (one of the most reputable sources on the industry and the metrics behind the cannabis sector), Aphria has valued Broken Coast’s productive capacity at more than $5,200 per square foot, while comparable production capacity has been built from scratch for approximately $333 per square foot.

In other words, Aphria just paid 15.7 times more than what it could have paid if it decided to buy land and build a production facility from scratch.

This isn’t even the most ridiculous valuation metric one can ascribe to the deal; taking into consideration how much Aphria just paid for access to Broken Coast’s loyal customers, an easy $23,000 per patient was paid to Broken Coast for the honour of selling pot to each of its customers! While other firms, such as Canopy Growth Corp., have paid more on a per-patient basis for other acquisitions (as high as $26,000 per patient), seeing these numbers makes my eyes water, as I consider how much pot must be sold to these customers over time to make up the exorbitant acquisition cost taken on the backs of Aphria equity holders.

Bottom line

The argument that Aphria is doing the right thing in issuing shares ($220 million out of the $230 million will come from new equity) to acquire firms requires some funny logic in addition to the funny math. The logic goes:

  • A first-mover advantage is the only important thing cannabis companies should be shooting for right now.
  • The amount paid for an acquisition really doesn’t matter, as the share price will continue to climb, and marijuana producers can simply issue new shares at higher prices, diluting the current shareholder base by smaller amounts over time.
  • Productive capacity is somehow worth 15 times more today than it would be in one or two years from now.

The math and the logic make no sense whatsoever. When money is free and valuations continue to go to new ridiculous levels, fundamentals mean less and less. Who knows when the sector will implode, but I can tell you, I will never step foot in this sector in 2018 and beyond, until fundamentals show some semblance of reality.

Stay Foolish, my friends.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

More on Investing

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Dividend Stocks

TFSA: Savvy Ways to Invest Your 2025 Contribution

No matter what your investing approach is, the key is to take full advantage of the tax-free room available in…

Read more »

calculate and analyze stock
Bank Stocks

Royal Bank of Canada: Buy, Sell, or Hold in 2025?

The TSX’s largest company by market capitalization is a buy-and hold stock for long-term investors.

Read more »

Man data analyze
Bank Stocks

TD Bank: Buy, Sell, or Hold in 2025?

TD Bank (TSX:TD) is historically seen as a great stock. But given its recent troubles, is it a buy, sell,…

Read more »

data analyze research
Investing

If I Could Only Buy 3 Stocks in 2025, I’d Pick These

These TSX stocks are set to benefit from lower interest rates, investments in AI, and increasing demand for power and…

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Monday, January 13

Renewed concerns about monetary policy are weighing on TSX investors’ sentiments despite rising commodity prices.

Read more »

data analyze research
Stocks for Beginners

Top Canadian Stocks to Buy With $5,000 in 2025

Got $5,000 that you want to invest in some long-term stock holdings? These Canadian stocks could be the ideal fit…

Read more »

Female raising hands enjoying vacation, standing on background of blue cloudless sky.
Dividend Stocks

CRA Update: The Basic Personal Amount Just Increased in 2025!

The BPA just increased, leaving Canadians with more cash in their pockets and room to make more cash!

Read more »

protect, safe, trust
Investing

2 Safe Dividend Stocks to Own in Any Market

Hydro One (TSX:H) and Loblaw (TSX:L) are defensive stocks to load up on regardless of the type of market environment.

Read more »